SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,194,342 | -62.3% | 51,100 | -57.1% | 0.39% | -62.8% |
Q1 2023 | $16,410,729 | -48.9% | 119,065 | -52.0% | 1.05% | -44.9% |
Q4 2022 | $32,130,009 | +105.5% | 247,955 | +75.3% | 1.91% | +109.6% |
Q3 2022 | $15,635,000 | +58.9% | 141,440 | +7.8% | 0.91% | +11.1% |
Q2 2022 | $9,838,000 | +41.7% | 131,245 | +47.7% | 0.82% | +55.4% |
Q1 2022 | $6,943,000 | -36.1% | 88,880 | -26.4% | 0.53% | -17.0% |
Q4 2021 | $10,872,000 | -25.3% | 120,732 | -23.2% | 0.64% | -26.2% |
Q3 2021 | $14,545,000 | -37.3% | 157,279 | -47.3% | 0.86% | -35.6% |
Q2 2021 | $23,205,000 | +162.5% | 298,500 | +475.7% | 1.34% | +154.2% |
Q4 2020 | $8,840,000 | -11.0% | 51,848 | -49.0% | 0.53% | -42.8% |
Q1 2020 | $9,938,000 | -12.3% | 101,603 | +15.7% | 0.92% | +12.5% |
Q4 2019 | $11,332,000 | +41.4% | 87,818 | -17.5% | 0.82% | +12.7% |
Q3 2019 | $8,016,000 | +50.2% | 106,414 | +117.6% | 0.72% | +9.0% |
Q4 2018 | $5,337,000 | +10.5% | 48,894 | +63.4% | 0.66% | +54.3% |
Q3 2018 | $4,832,000 | -31.5% | 29,915 | -44.0% | 0.43% | -4.2% |
Q2 2018 | $7,057,000 | – | 53,386 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
TOBAM | 371,107 | $27,659,000 | 1.18% |
Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |